Literature DB >> 23033650

Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice.

Mahaveer Golechha1, Jagriti Bhatia, Dharmveer Singh Arya.   

Abstract

Emblica officinalis, commonly known as amla, is an important medicinal plant of India. Its fruits have potent antioxidant activity due to the presence of tannoids, tannins, vitamin C and flavonoids. The aim of this study was to investigate the beneficial effect of the hydroalcoholic extract of the fruits of Emblica officinalis (EO) on memory impairment in Swiss albino mice. Scopolamine (1 mg kg(-1), i.p)was administered to induce amnesia and the memory was evaluated by using elevated plus-maze and passive avoidance tests. Piracetam (200 mg kg(-1), i.p.) was used as a standard nootropic agent. The EO extract was administered intraperitoneally in four graded doses (150, 300, 450 and 600 mg kg(-1)) for 7 consecutive days to different groups of mice. The mice were sacrificed on the 8th day following assessment of memory. The brain malondialdehyde (MDA) and glutathione (GSH) as well as acetylcholinesterase (AchE)) activity was determined. It was observed that EO extract reversed the amnesia induced by scopolamine. The mean transfer latency and retention latency in the EO extract 600 mg kg(-1) group vs the vehicle treated scopolamine group was 13.46 sec (p<0.001) and 134.4 sec (p<0.001) vs 23.99 sec and 44.55 sec, respectively. EO extract treatment also significantly (p<0.001) ameliorated the oxidative stress induced by scopolamine administration. The mice brain MDA and GSH levels in the EO extract 600 mg kg(-1) group vs the scopolamine group were 29.95 nmol g(-1) of wet tissue and 51.87 microg g(-1) tissue vs 55.22 nmol g(-1) of wet tissue and 28.33 microg g(-1) tissue, respectively. Further, EO extract (300, 450 and 600 mg kg(-1), i.p) significantly (p<0.001) reversed the rise in brain acetyl cholinesterase (AchE) level induced by scopolamine. The mice brain Ach E levels in the EO extract 600 mg kg(-1) group as compared to the scopolamine group was 70.23 vs 151.49 U mg(-1) protein(-1), respectively. These results suggestthat EO possesses memory enhancing, antioxidant and anti-cholinesterase activity. It may be useful for the treament of cognitive impairments induced by cholinergic dysfunction. Its potential in the management of dementia and Azheimer disease needs to be further explored.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033650

Source DB:  PubMed          Journal:  J Environ Biol        ISSN: 0254-8704


  12 in total

Review 1.  Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review.

Authors:  Ibraheem Husain; Saima Zameer; Tushar Madaan; Akram Minhaj; Wasim Ahmad; Asif Iqubaal; Abuzer Ali; Abul Kalam Najmi
Journal:  Metab Brain Dis       Date:  2019-03-08       Impact factor: 3.584

Review 2.  Avicenna's pharmacological approach to memory enhancement.

Authors:  Roja Rahimi; Shahrzad Irannejad; Maryam Noroozian
Journal:  Neurol Sci       Date:  2017-02-07       Impact factor: 3.307

3.  Evaluation of anti-amnesic effect of Conyza bonariensis in rats.

Authors:  Beenita Saikia; Lipika Buragohain; Chandana Choudhury Barua; Jadav Sarma; Sarojini Mahanta Tamuli; Dhruba Jyoti Kalita; Acheenta Gohain Barua; Iswar Chandra Barua; Ramakrishna Elancheran
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

4.  Evaluation of Cellular Antioxidant and Antiproliferative Activities of Five Main Phyllanthus Emblica L. Cultivars in China.

Authors:  Y Li; H Y Sun; X Y Yu; D Liu; H X Wan
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

5.  Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults.

Authors:  Savita Khanna; Amitava Das; James Spieldenner; Cameron Rink; Sashwati Roy
Journal:  J Med Food       Date:  2015-03-10       Impact factor: 2.786

6.  Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2-ARE Pathway.

Authors:  Ibraheem Husain; Mohd Akhtar; Tushar Madaan; Divya Vohora; Malik Z Abdin; Mohammad Islamuddin; Abul K Najmi
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

7.  In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease.

Authors:  Shereen K Ali; Ahmed R Hamed; Maha M Soltan; Usama M Hegazy; Esameldin E Elgorashi; Ibrahim A El-Garf; Ahmed A Hussein
Journal:  BMC Complement Altern Med       Date:  2013-05-30       Impact factor: 3.659

8.  Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin.

Authors:  Salma Malik; Kapil Suchal; Jagriti Bhatia; Sana I Khan; Swati Vasisth; Ameesha Tomar; Sameer Goyal; Rajeev Kumar; Dharamvir S Arya; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2016-10-03       Impact factor: 5.810

9.  Zanthoxylum alatum ameliorates scopolamine-induced amnesia in rats: Behavioral, biochemical, and molecular evidence.

Authors:  Beenita Saikia; Chandana C Barua; Jadav Sarma; Prakash Haloi; Sarojini M Tamuli; Dhruba J Kalita; Arundhati Purkayastha; Achinta G Barua
Journal:  Indian J Pharmacol       Date:  2018 Jan-Feb       Impact factor: 1.200

10.  Anti-Oxidant Activity of Gallotannin-Enriched Extract of Galla Rhois Can Associate with the Protection of the Cognitive Impairment through the Regulation of BDNF Signaling Pathway and Neuronal Cell Function in the Scopolamine-Treated ICR Mice.

Authors:  Ji Won Park; Ji Eun Kim; Mi Ju Kang; Hyeon Jun Choi; Su Ji Bae; Sou Hyun Kim; Young Suk Jung; Jin Tae Hong; Dae Youn Hwang
Journal:  Antioxidants (Basel)       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.